Skip to main content

Many Bright Ideas: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (MBI-H)

AI-generated - The Globe and Mail - Mon Oct 2, 2023

Many Bright Ideas is now ranked among the top 10 undervalued stocks in the Medical Diagnostics & Research industry on the Toronto Stock Exchange or TSX Venture Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Medical Diagnostics & Research: Companies that provide laboratory testing services through imaging and other diagnostic services to the medical industry.

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
MBI-HMany Bright Ideas0.010.020.01 (40.0%)47180.30.00.0
JUMPLeveljump Healthcare0.070.100.03 (35.4%)314656.50.018.8
SZLSStageZero Life Sciences0.060.070.02 (31.8%)423896.70.00.0

All data provided as-at market close October 02, 2023.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Many Bright Ideas

Medical Diagnostics & Research: Companies that provide laboratory testing services through imaging and other diagnostic services to the medical industry. Stocks in this category are held primarily for capital appreciation.

Many Bright Ideas is listed under MBI-H on the TSX Venture Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.